Agape ATP Corporation (NASDAQ:ATPC) Sees Large Decline in Short Interest

Agape ATP Corporation (NASDAQ:ATPC) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totaling 5,215 shares, a drop of 46.0% from the April 30th total of 9,663 shares. Based on an average daily trading volume, of 67,588 shares, the short-interest ratio is currently 0.1 days. Currently, 0.5% of the shares of the stock are sold short.

Agape ATP Stock Performance

Shares of NASDAQ:ATPC traded up $1.13 during trading on Wednesday, reaching $4.10. The stock had a trading volume of 3,709,770 shares, compared to its average volume of 2,491,397. The business has a fifty day moving average price of $2.71 and a 200-day moving average price of $12.06. The stock has a market cap of $4.10 million, a PE ratio of -3.08 and a beta of 0.08. Agape ATP has a 1-year low of $1.72 and a 1-year high of $85.50.

Agape ATP (NASDAQ:ATPC) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. The company had revenue of $0.27 million during the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on ATPC shares. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research report on Sunday, April 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a research report on Friday, May 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Institutional Investors Weigh In On Agape ATP

A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC lifted its position in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 at the end of the most recent reporting period. 0.01% of the stock is currently owned by hedge funds and other institutional investors.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.